U.S. President Donald Trump and Germany’s Merck KGaA on Thursday said they had struck a deal that would cut the cost of some drugs needed for in-vitro fertilization in exchange for protection from future tariffs.

Trump also said Merck would offer all new drugs launched in the U.S. at the prices it charges in other developed countries.

Trump said the German drugmaker’s U.S. arm, EMD Serono, had agreed to sell its fertility treatments, including Gonal-f, Ovidrel and Cetrotide, directly to consumers. Merck said when all three drugs are used in IVF , patients will get a combined discount of 84% off list price.

“We’re also taking historic steps to vastly expand access to insurance coverage for fertility care, including IVF, something that, as you know, was not covered,” Trump said from t

See Full Page